We are a collaborative network of Swiss researchers dedicated to preclinical and clinical cancer research in the field of urogenital tumors. Our network includes a scientific committee comprised of SAKK members and the Swiss cancer researchers, bringing together experts in the field.

Scientific Comittee

• Prof. Dr. med. Jean-Philippe Theurillat, IOR
• PD Dr. med. Petros Tsantoulis, HUG
• PD Dr. med. Mohamed Shelan, UCI
• Dr. Clémentine Le Magnen, USB

Keynote Speakers

• Prof. Dr. med. Bernhard Kiss, Inselspital Bern
• Prof. Dr. Bernd Bodenmiller, Universitätsspital Zürich USZ

Why you should join

One of our key objectives is to inspire and foster scientific interactions among the various basic, translational, and clinical research groups in the field of urogenital cancers in Switzerland. To facilitate this, we organize an annual networking meeting where researchers present their ongoing work and engage with partners to further develop their ideas or implement project goals.

Why it is worth to join

• Find a common ground for exchange between basic/translational researchers and clinical researchers in urogenital cancers in Switzerland
• Create awareness about unmet clinical needs
• Develop research ideas that may translate into clinical trials or subprojects of clinical trials in the SAKK Project Group Urogenital Tumors
• Mentor and support young physicians/scientists in uro-oncology in the project implementation process and their careers

Who you will meet

• Physicians (e.g., urologists, radiologists, oncologists, nuclear oncologists, pathologists)
• Basic researchers (e.g., molecular biologists, biochemists, immunologist, bioinformaticians)

Abstract submission

More information will follow

Awards

This year, we will present two awards. Please send your application to events@sakk.ch by September 30, 2024.
In case of any questions relating to the presentations, please contact Jean-Philippe Theurillat jean-philippe.theurillat@ior.usi.ch. For presenters of projects, participation at the event is free of charge (hotel and registration).

SAKK / ASTELLAS & ASTRAZENECA GU-ONCOLOGY RESEARCH AWARD
The Swiss Group for Clinical Cancer Research (SAKK) and Astellas & AstraZeneca are pleased to announce an award for 10 000 CHF aimed at supporting ongoing translational GU oncology research. The award is sponsored 50% by AstraZeneca and Astellas each. 

SAKK / NOVARTIS TRANSLATIONAL PROSTATE CANCER RESEARCH AWARD
The Swiss Group for Clinical Cancer Research (SAKK) and Novartis Pharma Schweiz AG are pleased to announce an award for 20 000 CHF aimed at supporting ongoing translational prostate cancer research.

More information will follow

Event Details

Event Language: English

CHF 160 without hotel room. Hotel rooms must be booked by the participants.
Special note: We do have provisional reservations at the Sorell Hotel Ador - if needed please let the Hotel know you are a participant from the SAKK Translational Urogenital Cancer Network Meeting.

More information will follow.